Search Results - "Stomach Neoplasms drug therapy"
-
1
Authors: et al.
Contributors: et al.
Source: Ann Surg Oncol
Annals of surgical oncology, vol. 31, no. 8, pp. 5273-5282Subject Terms: Male, Humans, Stomach Neoplasms/pathology, Stomach Neoplasms/mortality, Stomach Neoplasms/drug therapy, Stomach Neoplasms/surgery, Female, Neoadjuvant Therapy/mortality, Adenocarcinoma/mortality, Adenocarcinoma/pathology, Adenocarcinoma/drug therapy, Adenocarcinoma/surgery, Adenocarcinoma/therapy, Middle Aged, Retrospective Studies, Aged, Survival Rate, Follow-Up Studies, Propensity Score, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Chemotherapy, Adjuvant/mortality, Prognosis, Neoplasm Staging, Gastrectomy/mortality, Neoadjuvant therapy, Propensity score, Stomach neoplasms, Survival analysis, Gastrointestinal Oncology, Adenocarcinoma, Neoadjuvant Therapy, 03 medical and health sciences, 0302 clinical medicine, Stomach Neoplasms, Chemotherapy, Adjuvant, Gastrectomy, Antineoplastic Combined Chemotherapy Protocols
File Description: application/pdf
-
2
Authors: et al.
Contributors: et al.
Source: Gastric Cancer
Morgagni, P, Bencivenga, M, Carneiro, F, Cascinu, S, Derks, S, di Bartolomeo, M, Donohoe, C, Eveno, C, Gisbertz, S, Grimminger, P, Gockel, I, Grabsh, H, Kassab, P, Langer, R, Lonardi, S, Maltoni, M, Markar, S, Moehler, M, Marrelli, D, Mazzei, M A, Melisi, D, Milandri, C, Moenig, P S, Mostert, B, Mura, G, Polkowski, W, Reynolds, J, Saragoni, L, van Berge Henegouwen, M I, van Hillegersberg, R, Vieth, M, Verlato, G, Torroni, L, Wijnhoven, B, Tiberio, G A M, Yang, H-K, Roviello, F & de Manzoni, G 2024, 'International consensus on the management of metastatic gastric cancer : step by step in the foggy landscape: Bertinoro Workshop, November 2022', Gastric Cancer, vol. 27, no. 4, pp. 649-671. https://doi.org/10.1007/s10120-024-01479-5Subject Terms: Staging, Consensus, Delphi Technique, Consensu, 16. Peace & justice, Multimodal treatment, 3. Good health, Italy [MeSH], Stomach Neoplasms/therapy [MeSH], Humans [MeSH], Neoplasm Metastasis [MeSH], Stomach Neoplasms/pathology [MeSH], Original Article, Neoplasm Staging [MeSH], Stage IV, Oligometastatic gastric cancer, Stomach Neoplasms/drug therapy [MeSH], Delphi Technique [MeSH], Consensus [MeSH], Italy, Stomach Neoplasms, Humans, Neoplasm Metastasis, Neoplasm Staging
File Description: application/pdf; application/vnd.openxmlformats-officedocument.wordprocessingml.document; STAMPA
Access URL: https://pubmed.ncbi.nlm.nih.gov/38634954
https://research.vumc.nl/en/publications/04afdba3-22f1-47ac-bd68-8ff4f6fa626c
https://hdl.handle.net/11365/1281117
https://link.springer.com/article/10.1007/s10120-024-01479-5
https://doi.org/10.1007/s10120-024-01479-5
https://hdl.handle.net/11562/1125011
https://doi.org/10.1007/s10120-024-01479-5
https://hdl.handle.net/11379/604146
https://doi.org/10.1007/s10120-024-01479-5
https://repository.publisso.de/resource/frl:6505230
https://link.springer.com/article/10.1007/s10120-024-01479-5
https://hdl.handle.net/11585/969747
https://doi.org/10.1007/s10120-024-01479-5 -
3
Authors: et al.
Source: Nat Med
Verschoor, Y L, van de Haar, J, van den Berg, J G, van Sandick, J W, Kodach, L L, van Dieren, J M, Balduzzi, S, Grootscholten, C, IJsselsteijn, M E, Veenhof, A A F A, Hartemink, K J, Vollebergh, M A, Jurdi, A, Sharma, S, Spickard, E, Owers, E C, Bartels-Rutten, A, den Hartog, P, de Miranda, N F C C, van Leerdam, M E, Haanen, J B A G, Schumacher, T N, Voest, E E & Chalabi, M 2024, 'Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma : the phase 2 PANDA trial', Nature Medicine, vol. 30, no. 2, pp. 519-530. https://doi.org/10.1038/s41591-023-02758-x
Nature medicine, vol. 30, no. 2, pp. 519-530Subject Terms: Humans, Neoadjuvant Therapy, Programmed Cell Death 1 Receptor, Adenocarcinoma/drug therapy, Adenocarcinoma/pathology, Stomach Neoplasms/drug therapy, Stomach Neoplasms/pathology, Esophagogastric Junction/pathology, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Tumor Microenvironment, Esophageal Neoplasms, Antibodies, Monoclonal, Humanized, Stomach Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Esophagogastric Junction, Adenocarcinoma, Article, 3. Good health
File Description: application/pdf
Access URL: https://pubmed.ncbi.nlm.nih.gov/38191613
https://research.vumc.nl/en/publications/bfeaedeb-60c1-4b56-80af-f9c510c6ffeb
https://serval.unil.ch/resource/serval:BIB_CFF0D10D1EFA.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_CFF0D10D1EFA2
https://serval.unil.ch/notice/serval:BIB_CFF0D10D1EFA
https://hdl.handle.net/1887/3720855 -
4
Authors: et al.
Source: Br J Cancer
Subject Terms: 0301 basic medicine, ddc:610, 0303 health sciences, Adenocarcinoma, Prognosis, Risk Assessment, Article, Risk Assessment [MeSH], Humans [MeSH], Stomach Neoplasms/pathology [MeSH], 692/53/2422, 631/67/1504/1829, Stomach Neoplasms/surgery [MeSH], Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], Adenocarcinoma/pathology [MeSH], Prognosis [MeSH], Stomach Neoplasms/drug therapy [MeSH], Biomarkers [MeSH], article, 3. Good health, 03 medical and health sciences, Stomach Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Humans, Biomarkers
File Description: application/pdf
-
5
Authors: et al.
Source: Cancer treatment reviews, vol. 134, pp. 102890
Subject Terms: Humans, Adenocarcinoma/drug therapy, Adenocarcinoma/genetics, Adenocarcinoma/pathology, Adenocarcinoma/therapy, Esophageal Neoplasms/drug therapy, Esophageal Neoplasms/genetics, Esophageal Neoplasms/pathology, Microsatellite Instability, Stomach Neoplasms/drug therapy, Stomach Neoplasms/genetics, Stomach Neoplasms/pathology, Stomach Neoplasms/therapy, DNA Mismatch Repair, Immune Checkpoint Inhibitors/therapeutic use, Esophageal cancer, Gastric cancer, Immune checkpoint inhibitors, MSI, dMMR/MSI gastro-esophageal adenocarcinoma
File Description: application/pdf
Relation: info:eu-repo/semantics/altIdentifier/pmid/39933210; info:eu-repo/semantics/altIdentifier/eissn/1532-1967; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_60CAA9C4CEC97; https://serval.unil.ch/notice/serval:BIB_60CAA9C4CEC9; https://serval.unil.ch/resource/serval:BIB_60CAA9C4CEC9.P001/REF.pdf
-
6
Authors: et al.
Source: Annals of Surgical Oncology. 30:4433-4441
Subject Terms: Adult, Aerosols, Peritoneal Neoplasms/drug therapy, Middle Aged, 3. Good health, Young Adult, Stomach Neoplasms, Doxorubicin, Humans, Feasibility Studies, Stomach Neoplasms/drug therapy, Female, Laparoscopy, Prospective Studies, Cisplatin, Peritoneal Neoplasms, Aged
-
7
Authors: et al.
Contributors: et al.
Source: BMB Rep
Subject Terms: 0301 basic medicine, Tumor, Epithelial-Mesenchymal Transition, Apoptosis, Article, Cell Line, Stomach Neoplasms* / drug therapy, 03 medical and health sciences, Antineoplastic Agents* / therapeutic use, Antineoplastic Agents* / pharmacology, Stomach Neoplasms* / pathology, Humans, Stomach Neoplasms* / genetics
-
8
Authors: et al.
Contributors: et al.
Source: The Lancet Oncology. 23:1558-1570
Subject Terms: Follicular, Diarrhea, 0301 basic medicine, Bispecific, Lymphoma, Esophageal Neoplasms, Antineoplastic Agents, Antibodies, 3. Good health, Stomach Neoplasms* / drug therapy, 03 medical and health sciences, 0302 clinical medicine, Stomach Neoplasms, Antibodies, Bispecific, Humans, Colorectal Neoplasms, Stomach Neoplasms* / genetics, Lymphoma, Follicular
Access URL: https://pubmed.ncbi.nlm.nih.gov/36400106
-
9
Authors: et al.
Contributors: et al.
Source: European Journal of Cancer. 172:387-399
Subject Terms: 0301 basic medicine, Advanced gastric cancer, Programmed Cell Death 1 Receptor, PD-1 blockade, Irinotecan, Immune Checkpoint Inhibitors / adverse effects, 3. Good health, Stomach Neoplasms* / drug therapy, Hypoalbuminemia, 03 medical and health sciences, Hyperprogressive disease, 0302 clinical medicine, Stomach Neoplasms, Disease Progression, Humans, Irinotecan / adverse effects, Immune Checkpoint Inhibitors
Access URL: https://pubmed.ncbi.nlm.nih.gov/35839733
-
10
Authors: et al.
Contributors: et al.
Source: Gastric Cancer. 25:1039-1049
Subject Terms: Stomach Neoplasms* / surgery, Neoadjuvant Therapy, Middle Aged, Prognosis, Neoadjuvant chemotherapy, Clinical stage, 3. Good health, Stomach Neoplasms* / drug therapy, Survival Rate, Post-neoadjuvant chemotherapy pathological stage, 03 medical and health sciences, 0302 clinical medicine, Stomach Neoplasms, Antineoplastic Combined Chemotherapy Protocols / therapeutic use, Antineoplastic Combined Chemotherapy Protocols, Humans, Gastric cancer, Neoplasm Staging, Retrospective Studies
Access URL: https://pubmed.ncbi.nlm.nih.gov/35920999
-
11
Authors: et al.
Contributors: et al.
Source: Clinical Cancer Research. 28:3489-3498
Subject Terms: Antineoplastic Combined Chemotherapy Protocols* / therapeutic use, Tumor, Esophageal Neoplasms, Adenocarcinoma, Antibodies, Monoclonal, Humanized, Antibodies, 3. Good health, Stomach Neoplasms* / drug therapy, 03 medical and health sciences, 0302 clinical medicine, Humanized* / therapeutic use, Stomach Neoplasms, 03 Salud y bienestar, Monoclonal, Antineoplastic Combined Chemotherapy Protocols, Biomarkers, Tumor, Humans, 03 Good Health and Well-being, Microsatellite Instability, Stomach Neoplasms* / genetics, Biomarkers
Access URL: https://pubmed.ncbi.nlm.nih.gov/35657979
-
12
Authors: et al.
Contributors: et al.
Source: American Journal of Hypertension. 35:731-739
Subject Terms: Stomach Neoplasms* / complications, Adult, Male, hypertension, Kidney Neoplasms* / epidemiology, Antihypertensive Agents / adverse effects, Blood Pressure, Kidney Neoplasms* / complications, 03 medical and health sciences, 0302 clinical medicine, Risk Factors, Stomach Neoplasms, cancer, Humans, Antihypertensive Agents, Incidence, blood pressure, Hypertension* / epidemiology, Middle Aged, Kidney Neoplasms, Hypertension* / complications, 3. Good health, Stomach Neoplasms* / drug therapy, Hypertension* / diagnosis, Colorectal Neoplasms* / epidemiology, Hypertension, Blood Pressure / physiology, epidemiology, Female, Colorectal Neoplasms* / diagnosis, Colorectal Neoplasms
Access URL: https://pubmed.ncbi.nlm.nih.gov/35512273
-
13
Authors: et al.
Source: Mol Cancer
Molecular Cancer, Vol 23, Iss 1, Pp 1-8 (2024)Subject Terms: 0301 basic medicine, 0303 health sciences, Pyridines, Research, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Adenocarcinoma, Personalized medicine, Combined Modality Therapy, Neoadjuvant Therapy, 3. Good health, Carbamates [MeSH], Gastric cancer, Patient-derived organoids, Pyridines [MeSH], Organoids [MeSH], Humans [MeSH], Neoadjuvant Therapy [MeSH], Adenocarcinoma/drug therapy [MeSH], Stomach Neoplasms/drug therapy [MeSH], Response prediction, Combined Modality Therapy [MeSH], Fluorouracil/pharmacology [MeSH], Pyrazines [MeSH], Organoids, 03 medical and health sciences, Stomach Neoplasms, Pyrazines, Humans, Fluorouracil, Carbamates, RC254-282
-
14
Authors: et al.
Contributors: et al.
Source: The Lancet Oncology. 23:234-247
Subject Terms: Adult, Male, 0301 basic medicine, Esophageal Neoplasms / mortality, Esophageal Neoplasms, Receptor, ErbB-2, Stomach Neoplasms / drug therapy, 03 medical and health sciences, 0302 clinical medicine, Esophageal Neoplasms / drug therapy, Nivolumab / therapeutic use, Double-Blind Method, Stomach Neoplasms, Antineoplastic Combined Chemotherapy Protocols, 80 and over, Humans, Aged, Aged, 80 and over, Local / drug therapy, Antineoplastic Combined Chemotherapy Protocols / therapeutic use, Esophagogastric Junction, 3. Good health, Neoplasm Recurrence, Nivolumab, ErbB-2 / analysis, Stomach Neoplasms / mortality, Female, Neoplasm Recurrence, Local, Receptor
Access URL: https://pubmed.ncbi.nlm.nih.gov/35030335
-
15
Authors: et al.
Source: Ann Surg Oncol
Annals of surgical oncology, vol. 31, no. 9, pp. 6038-6039Subject Terms: Survival Rate, Humans, Stomach Neoplasms/drug therapy, Stomach Neoplasms/pathology, Neoadjuvant Therapy/methods, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Practice Guidelines as Topic/standards, Chemotherapy, Adjuvant, Prognosis, Neoplasm Staging, Stomach Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Practice Guidelines as Topic, ASO Author Reflections, Neoadjuvant Therapy
File Description: application/pdf
-
16
Authors: et al.
Source: Baxter, M A, Spender, L C, Cairns, D, Walsh, S, Oparka, R, Porter, R J, Bray, S, Skinner, G, King, S, Turbitt, J, Collinson, D, Miedzybrodzka, Z H, Jellema, G, Logan, G, Kennedy, R D, Turkington, R C, McLean, M H, Swinson, D, Grabsch, H I, Lord, S, Seymour, M J, Hall, P S & Petty, R D 2024, 'An investigation of the clinical impact and therapeutic relevance of a DNA damage immune response (DDIR) signature in patients with advanced gastroesophageal adenocarcinoma', ESMO Open, vol. 9, no. 5, 103450. https://doi.org/10.1016/j.esmoop.2024.103450
Subject Terms: Humans, immune checkpoint inhibitors, Immune Checkpoint Inhibitors - therapeutic use - pharmacology, Tumor Microenvironment - immunology, Adenocarcinoma - drug therapy - immunology - genetics, gastroesophageal adenocarcinoma, Aged, Male, DNA Damage, Middle Aged, DNA damage immune response, Biomarkers, Tumor - metabolism, tumour microenvironment, Esophageal Neoplasms - drug therapy - immunology - genetics, Female, epidermal growth factor receptor, ErbB Receptors - metabolism, Stomach Neoplasms - drug therapy - immunology - genetics
File Description: application/pdf
-
17
Authors: et al.
Contributors: et al.
Source: Cancer Discov
Subject Terms: 0301 basic medicine, 0303 health sciences, Platinum / pharmacology, Genomics, 3. Good health, Stomach Neoplasms* / drug therapy, 03 medical and health sciences, Stomach Neoplasms, Antineoplastic Combined Chemotherapy Protocols / therapeutic use, Antineoplastic Combined Chemotherapy Protocols, Tumor Microenvironment, Humans, Antineoplastic Combined Chemotherapy Protocols / pharmacology, Platinum / therapeutic use, Stomach Neoplasms* / genetics, Research Articles, Platinum
Access URL: https://pubmed.ncbi.nlm.nih.gov/34933901
-
18
Authors: et al.
Contributors: et al.
Source: Nature. 600:727-730
Subject Terms: ErbB-2* / metabolism, Receptor, ErbB-2, Programmed Cell Death 1 Receptor* / antagonists & inhibitors, Esophagogastric Junction / drug effects, Programmed Cell Death 1 Receptor, Adenocarcinoma / pathology, Adenocarcinoma, Antibodies, Monoclonal, Humanized, Antibodies, Humanized* / therapeutic use, ErbB-2* / antagonists & inhibitors, Stomach Neoplasms, Humanized* / pharmacology, Monoclonal, Antineoplastic Combined Chemotherapy Protocols / therapeutic use, Antineoplastic Combined Chemotherapy Protocols, Humans, Antineoplastic Combined Chemotherapy Protocols / pharmacology, Esophagogastric Junction / pathology, Trastuzumab* / therapeutic use, Trastuzumab, 3. Good health, Stomach Neoplasms* / drug therapy, Trastuzumab* / pharmacology, Stomach Neoplasms* / pathology, Stomach Neoplasms* / metabolism, Adenocarcinoma / drug therapy, Esophagogastric Junction, Receptor
Access URL: https://pubmed.ncbi.nlm.nih.gov/34912120
-
19
Authors: et al.
Contributors: et al.
Source: Cellular Oncology. 44:1387-1403
Subject Terms: Transcription Factors / antagonists & inhibitors, 0301 basic medicine, Paclitaxel, Nude, Mice, Nude, Cell Cycle Proteins / metabolism, Cell Cycle Proteins, Stomach Neoplasms / drug therapy, Organoids / pathology, BET inhibitor, BET protein, Genetic* / drug effects, Organoids / drug effects, Cell Line, Epigenetic regulation, Epigenesis, Genetic, Tumor / metabolism, Mice, 03 medical and health sciences, GC organoid, Stomach Neoplasms, Cell Line, Tumor, Biomarkers, Tumor, Cell Adhesion, Animals, Molecular Targeted Therapy, Combination therapy, Inbred BALB C, Cell Proliferation, Mice, Inbred BALB C, Tumor, Transcription Factors / metabolism, Cell Death, Paclitaxel / pharmacology, Drug Synergism, Cell Cycle Checkpoints, Stomach Neoplasms / genetics, Xenograft Model Antitumor Assays, 3. Good health, Organoids, Female, Paclitaxel / therapeutic use, Gastric cancer, Biomarkers, Epigenesis, Transcription Factors
-
20
Authors: et al.
Source: Br J Cancer
Subject Terms: Adult, Aged, 80 and over, Male, 0301 basic medicine, ddc:610, Middle Aged, Article, Neoadjuvant Therapy, ddc, 3. Good health, 03 medical and health sciences, Gastric cancer, Stomach Neoplasms/genetics [MeSH], Female [MeSH], Aged, 80 and over [MeSH], Chromosomal Instability/genetics [MeSH], Aged [MeSH], Surgical oncology, Prognostic markers, Adult [MeSH], Humans [MeSH], Predictive markers, Middle Aged [MeSH], Neoadjuvant Therapy/methods [MeSH], Male [MeSH], Stomach Neoplasms/drug therapy [MeSH], Stomach Neoplasms, Chromosomal Instability, Humans, Female, Aged
File Description: application/pdf
Access URL: https://www.nature.com/articles/s41416-021-01587-4.pdf
https://pubmed.ncbi.nlm.nih.gov/34671125
https://www.nature.com/articles/s41416-021-01587-4
https://www.nature.com/articles/s41416-021-01587-4.pdf
https://repository.publisso.de/resource/frl:6442862
https://mediatum.ub.tum.de/doc/1704374/document.pdf
Full Text Finder 
Nájsť tento článok vo Web of Science 
Full Text